Collaboration Aims to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
| Date | 5th, Oct 2022 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
The University of Texas MD Anderson Cancer Center and ARTIDIS AG today announced a strategic alliance to investigate ARTIDIS technology as a novel treatment-optimization tool for patients with solid tumors in several distinct indications.